Brian Armstrong

Who they are

Brian Armstrong is co-founder and CEO of Coinbase — started UniversityTutor.com in 2003 as a student and later co-founded NewLimit, a longevity biotech using epigenetic reprogramming to reverse aging.

Person

Armstrong co-founded Coinbase in 2012 out of a small San Francisco apartment, at a moment when there were essentially no compliant crypto on-ramps for ordinary Americans. Before that, he was a software engineer at Airbnb and a consultant in enterprise risk management at Deloitte — a practical, compliance-aware background that proved useful when regulators eventually came knocking. He graduated Rice University in 2006 with a B.S. and M.S. in Computer Science and a B.A. in Economics, and had already built UniversityTutor.com, an online tutoring marketplace, in 2003 while still a student. Beyond Coinbase, he's founded or incubated four other ventures: NewLimit (2021), a longevity biotech co-founded with Blake Byers and Jacob Kimmel that uses AI and epigenetics to develop age-reversing therapies; ResearchHub (2020), a GitHub-style scientific collaboration platform; GiveCrypto.org, a nonprofit distributing cryptocurrency globally; and the original UniversityTutor.com. He writes at brianarmstrong.org on crypto adoption, regulation, financial freedom, longevity research, and entrepreneurship, and has appeared on Tim Ferriss (#627), Lex Fridman (#307), Bloomberg Talks, Conversations with Tyler, and Davos. The through-line across everything — compliance-first exchange, lobbying for FIT21, longevity science, charter cities — is a conviction that incumbent systems are fragile and that building new infrastructure is the only way to fix them.

Company

Coinbase's most active recent move is its push to become an 'everything exchange': in early 2026 it launched stock trading and prediction markets across all 50 U.S. states, and has stated plans to integrate crypto, equities, derivatives, and commodities on a single platform. The Deribit acquisition — completed May 8, 2025 for $2.9 billion — was the foundation of that derivatives ambition, and Q1 2026 results showed record derivatives trading revenue alongside $1.4 billion in total quarterly revenue. Coinbase also secured a MiCA license and opened a Luxembourg hub giving it access to all 27 EU states, received conditional OCC approval to establish a national trust bank, and in 2026 received a Financial Services Permission from Abu Dhabi Global Market for an international tokenization hub — signaling a deliberate geographic diversification beyond the U.S. On the product side, 2025 saw the Base chain's Flashblocks upgrade cut block times to 200ms, the launch of the Coinbase One Card with bitcoin rewards, and the introduction of the x402 stablecoin payment standard enabling AI agents to transact with stablecoins. Armstrong publicly withdrew support for the Senate Banking Committee's draft Digital Asset Market Clarity Act in early 2026, citing concerns about privacy provisions, a tokenized equities ban, and stablecoin yield restrictions — a notable tension with Washington even as the regulatory climate broadly improved following the SEC's February 2025 dismissal of its landmark case against Coinbase.

Market

Coinbase holds a 10.3% share of global crypto trading volume as of Q2 2026 and is the largest U.S. crypto exchange by volume, serving as custodian for 9 of 11 Bitcoin ETFs and 8 of 9 Ethereum ETFs — a structural lock-in with institutional finance that its rivals lack. Binance, with 39.8% global market share as of July 2025, remains the dominant volume player globally; Kraken is the closest U.S. rival with strong institutional and EU positioning; Gemini, Robinhood, and OKX compete across retail and derivatives. The broader regulatory shift — FIT21 passed in 2025, the SEC case dropped, MiCA creating an EU framework, spot Bitcoin and Ethereum ETFs approved in late 2024 — has broadly benefited Coinbase, though New York's April 2026 lawsuit alleging $3.9 billion in damages over prediction market gambling law violations is a live legal risk.

Network

Armstrong's closest professional ties are Fred Ehrsam, his Coinbase co-founder, and Ben Horowitz of a16z, a long-standing backer and public conversation partner. At NewLimit, he works alongside co-founders Blake Byers and Jacob Kimmel. Inside Coinbase, his senior team includes Shan Aggarwal (Chief Business Officer, promoted August 2025), with Paul Grewal (Chief Legal Officer) having departed after the key regulatory wins.

Fred Ehrsam· Co-founder, Coinbase
Ben Horowitz· General Partner, Andreessen Horowitz
Blake Byers· Co-founder, NewLimit
Jacob Kimmel· Co-founder, NewLimit
Shan Aggarwal· Chief Business Officer, Coinbase
Paul Grewal· Former Chief Legal Officer, Coinbase (departed)

How they likely show up

Long-tenure founder role (co-founded Coinbase in 2012 and has led it continuously) → thinks in decade-long arcs; unlikely to be swayed by short-term market noise.
Publicly withdrew support for a Senate crypto bill in early 2026 on specific technical grounds (privacy, tokenized equities ban, stablecoin yield) → engages policy at clause-level detail, not headline level.
Five founded or co-founded ventures running concurrently (Coinbase, NewLimit, ResearchHub, GiveCrypto, UniversityTutor) → extremely high agency; probably bored by passive discussion and energized by building.
Tim Ferriss episode titled 'The Art of Relentless Focus' → self-identifies focus as a core discipline; likely prioritizes ruthlessly and expects others to do the same.
Active public writer at brianarmstrong.org and on Medium, covering crypto regulation, financial freedom, and longevity → comfortable with first-principles arguments and expects substantive engagement, not surface agreement.
Background in enterprise risk management at Deloitte before founding Coinbase → treats regulatory and compliance strategy as a competitive moat, not a burden.

Conversation tips

→ Come in with a specific, clause-level view on crypto regulation — he withdrew support for the CLARITY Act over specific provisions; vague takes on 'regulatory clarity' won't land.
→ Ask about the 'everything exchange' ambition — integrating crypto, equities, prediction markets, and commodities is a live strategic bet and he'll have strong views on the sequencing.
→ Reference the NewLimit work if it's genuinely relevant — epigenetic reprogramming and longevity science is a serious personal conviction, not a hobby, and he's committed significant personal capital to it.
→ Don't waste time on the origin story; he's told the Coinbase founding narrative hundreds of times. Move quickly to what's live and contested.
→ He responds well to first-principles arguments over appeals to industry consensus — frame your points as structural reasoning, not 'this is how it's done.'

Toolbox

Openers

Open on the CLARITY Act withdrawal — he publicly pulled support in January 2026 over specific provisions on privacy, tokenized equities, and stablecoin yield, stalling a bill Coinbase had long lobbied for. That's a pointed, high-stakes call worth unpacking.
Lead with NewLimit's $130M raise — he co-founded a longevity biotech in 2021 with Blake Byers and Jacob Kimmel to develop epigenetic reprogramming therapies, and is personally funding age-reversal science while running a public company. It's an unusual combination that he clearly cares about.
Open on the 'everything exchange' product direction — Coinbase launched stock trading and prediction markets across all 50 states in 2026 and is publicly planning to integrate equities, derivatives, and commodities. It's the most active strategic bet in the company right now.

Discovery questions

You withdrew support for the CLARITY Act over privacy provisions and the tokenized equities ban — what would a bill you could actually sign onto look like, and do you think Congress can get there?
The Deribit acquisition gave you the derivatives infrastructure, and you've now added stock trading and prediction markets — what does the sequencing look like to get from here to a genuine 'everything exchange,' and what's the hardest integration problem?
NewLimit is running simultaneously with Coinbase — how do you think about the resource allocation between them, and what would have to be true for epigenetic reprogramming therapies to reach clinical use in the next decade?

Avoid

Don't treat crypto regulation as a settled win — he publicly broke with the Senate over the CLARITY Act in early 2026 and is simultaneously facing a $3.9 billion New York lawsuit over prediction markets; the regulatory picture is still actively contested and he knows it in granular detail.

Make it yours